Videos

Interpreting MART-1 Immunohistochemistry Frozen Sections

Featuring Justin Leitenberger, MD, FACMS

© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.

05/16/2023

In this interview, Dr Leitenberger discusses his session, “Mohs for Melanoma Immunohistochemistry (IHC) Refresher,” at the 2023 ACMS Annual Meeting. He covered the topic, "Mohs IHC Interpretation."

Justin Leitenberger, MD, FACMS, is an associate professor, director of dermatologic surgery, and associate program director of the micrographic surgery and dermatologic oncology fellowship at Oregon Health and Science University (OHSU) in Portland, OR. He is also the president of the International Immunosuppression and Transplant Skin Cancer Collaborative.

Read Dr Leitenberger's interview transcript!

Current Issue

October 2024

Volume 32

Issue 7

Current Issue

Issue Archive

Popular Articles

Cosmetic Clinic

Filling the Face, Part 1

04/10/2012

The first of this three-part series addresses treating early signs of aging in the upper third of the face.

The first of this three-part...

04/10/2012

The Dermatologist

NEA Approved Features

Dupilumab for Pediatric Atopic Dermatitis: Tips From Dr Amy Paller

06/17/2021

Lauren Mateja ;

As the first advanced therapy approved for atopic dermatitis, dupilumab offers an efficacious option for moderate to severe disease. Dr Amy Paller offers insights on how this biologic can help pediatric patients with eczema and their...

As the first advanced therapy...

06/17/2021

The Dermatologist

Pharmaceutical Payments to Doctors Posted Online

01/12/2012

The 2010 healthcare reform law contains provisions for posting pharmaceutical company compensation to doctors online. Fees could include those paid for participation on a speaker’s bureau, consulting, research and attending dinner. A backlash...

The 2010 healthcare reform law...

01/12/2012

The Dermatologist

News

Antiepileptic Drugs are the Most Common Causative Agents of TEN and TEN/SJS Overlap

06/24/2021

Lisa Kuhns , PhD, MD;

Several drugs that have emerged since 1990 are a cause of toxic epidermal necrolysis (TEN) and TEN and Stevens-Johnson syndrome overlap.

Several drugs that have emerged...

06/24/2021

The Dermatologist

Spotlight

Spotlight on: Dr. Leonard Goldberg

09/12/2011

In dermatology, we are fortunate to have many insightful practitioners and great teachers and mentors. Some are bright stars in our special universe — others unsung heroes. All of these colleagues have much to share from wisdom to humor to...

In dermatology, we are fortunate...

09/12/2011

The Dermatologist

The Dermatologist Newsletter

Latest Quizzes and Trivia

Quiz

Pediatric Atopic Dermatitis Management

11/11/2024

Riya Gandhi , MA;

1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...

1. What alternative therapies...

11/11/2024

The Dermatologist

QUIZ

Test Your Knowledge: The Immunology of Alopecia Areata

11/04/2024

The Dermatologist

Quiz

Long-Term Safety of Risankizumab

10/18/2024

Jessica Garlewicz ;

What were the primary findings regarding the long-term safety of risankizumab?

What were the primary findings...

10/18/2024

The Dermatologist

Quiz

Barriers to Mental Health Support

10/10/2024

Riya Gandhi , MA;

What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?

What was the first barrier to...

10/10/2024

The Dermatologist

Quiz

QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies

09/15/2024

Riya Gandhi , MA;

1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...

1. According to Dr Linda Stein...

09/15/2024

The Dermatologist

Quiz

QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis

08/10/2024

Riya Gandhi , MA;

What strategies did Dr Merola emphasize for atopic dermatitis?

What strategies did Dr Merola...

08/10/2024

The Dermatologist

contact dermtitis + Neck + Eczema + rash

Quiz

QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing

07/14/2024

What is a common challenge for patients during the patch testing week?

What is a common challenge for...

07/14/2024

The Dermatologist

Quiz

Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis

05/30/2024

Riya Gandhi , MA;

According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?

According to a recent interview...

05/30/2024

The Dermatologist

Quiz

Quiz: Atopic Dermatitis Spotlight

05/06/2024

Riya Gandhi , MA;

Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?

Which class of medications...

05/06/2024

The Dermatologist

Quiz

True or False: Basal Cell Carcinoma on Vermilion Lip

05/01/2024

Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?

Is basal cell carcinoma on the...

05/01/2024

The Dermatologist